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Abstract
Title: Anesthetic Considerations for the Parturient with Idiopathic Intracranial Hypertension
Background: Idiopathic intracranial hypertension (IIH) is a rare condition occurring in one in
about every 5,000 obese women of child-bearing age. The disease process places affected
patients at risk for permanent vision loss if treated improperly. Disease pathology, management
and anesthetic considerations are important to avoid this potential unfortunate outcome.
Purpose: The purpose of this independent project is to present a case report of a parturient with
idiopathic intracranial hypertension and provide anesthesia practitioners with a comprehensive
evidence-based review of the anesthetic considerations for the parturient with the disease.
Process: A literature review was conducted using the UND Health Sciences Library through the
University of North Dakota. Databases searched within the library included the Cochrane
Library, PubMed, CINAHL, & SCOPUS. Each article identified through these databases were
scrutinized for inclusion within the literature review.
Results: IIH is an uncommon condition with a high risk of morbidity if there is poor anesthetic
planning. The patient may be allowed to labor and undergo vaginal or cesarean delivery.
Epidural anesthetics should be administered carefully, and boluses should be avoided making
this an unwise choice with the risk of any labor course requiring an emergent cesarean delivery.
Spinal anesthetics may be employed if there is no lumboperitoneal (LP) shunt present. Use of an
intrathecal catheter is beneficial for the administration of medications, monitoring of cerebral
spinal fluid pressures, and treatment of therapeutic removal of cerebrospinal fluid (CSF) if the
patient’s neurologic condition deteriorates. With the presence of an LP shunt, epidural
anesthesia is possible and with care exercised for correct interspace placement and removal of
the catheter to avoid damaging of the shunt. Although there is a fair amount of research on the
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medical management of IIH, research on the anesthetic implications for patients with the
condition is fairly limited. No national guidelines exist for obstetrical care of the parturient with
IIH. Further research is required to produce a consistent guide for treatment in this patient
population.
Implications: To allow for safe anesthetic planning, it is crucial that the anesthetic provider
understands the pathophysiology, medical and surgical management, and anesthetic implications
involved in caring for the parturient with IIH to avoid potentially irreversible neurological
complications.
Keywords: Idiopathic intracranial hypertension, benign intracranial hypertension, pseudotumor
cerebri, obstetrical anesthesia, pregnancy, neuraxial anesthesia, cesarean section.

PARTURIENT AND IDIOPATHIC INTRACRANIAL HYPERTENSION

5

Anesthetic Considerations for the Parturient with Idiopathic Intracranial Hypertension
The anesthetist’s role in obstetrics has become increasingly important with nearly four
million births per year in the United States of which 32% of all births come through cesarean
section (Martin, Hamilton, Osterman, Driscoll, & Mathews, 2017). Osterman and Martin
(2011) report that 61% of parturients received a spinal or epidural anesthetic to aid with their
delivery in 2008. According to the American Society of Anesthesiologists (2016), obstetrical
anesthesia refers to anesthetic and analgesic interventions delivered in the peri-partum timeframe
to relieve pain associated with labor, vaginal delivery, cesarean delivery, the removal of retained
placenta, or post-partum tubal ligation. Although the females receiving obstetrical services are
usually healthy, co-existing conditions may exist that may complicate the anesthetic plan.
Idiopathic Intracranial Hypertension (IIH) is a rare but serious condition that has
implications for obstetrical anesthesia (Kesler & Kupferminc, 2013). IIH, also known as
pseudotumor cerebri or benign intracranial hypertension, is a rare condition that causes an
increase of intracranial pressure (ICP) without a determined pathology existing in the brain or
cerebral spinal fluid (CSF) composition (Karmaniolou, Petropoulos, & Theodoraki, 2011).
Because common forms of obstetrical anesthesia include epidural and spinal anesthetics, it is
important to understand the pathophysiology of IIH, the disease management, and the anesthetic
implications for this rare patient population to avoid unfortunate neurologic sequelae (Kesler &
Kupferminc, 2013). According to Month and Vaida (2012), IIH occurs in 0.9 per every 100,000
people in the general population but increases to 3.3 per every 100,000 women ages 15-44. Bell
(2016) reports the prevalence of IIH in obese women ages 15-44 years old at up to 21.4 women
in every 100,000. Much has been written about the medical and surgical management of IIH.
These interventions are important factors that may impact the anesthetic plans for patients
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undergoing either vaginal or cesarean deliveries. Understanding of the disease management is
critical for this patient population as it carries high consequence for mismanagement of
anesthetic plans.
Further research is required for the understanding of the pathophysiology of IIH among
anesthetists and the impact of the condition on anesthetic choices. In the following pages, a case
report of a patient with IIH will be discussed, as well as, an extensive literature review of the
topic.
Purpose
The purpose of this independent study is to review a case report of anesthetic
management of a patient with IIH undergoing a cesarean section delivery. A literature review
will also be reported on the pathophysiology of the condition and the anesthetic implications it
has for the parturient population. This topic, although rare, has important implications for the
anesthetist related to the morbidity associated with mismanagement of the condition.
Case Report
A 21-year-old primiparous female presented at 37-weeks gestation for a planned cesarean
delivery due to fetal presentation in the breech position. Her pregnancy was complicated with
neck and shoulder pain of unknown origin that progressed to ringing in the ears, dizziness,
nausea, vomiting, headache, and blurred vision. A diagnosis of IIH with papilledema was made
after consultation with neurology and ophthalmology. After her initial diagnosis, she had been
managed with one therapeutic lumbar puncture to drain excessive CSF in attempt to reduce
pressure ICP. She was then managed medically with acetazolamide scheduled four times daily.
During her pre-operative assessment, she was noted to be 160 cm tall and 155.5 kg. She
was alert and oriented and answering questions appropriately. She complained of a mild
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headache but denied visual disturbances. Other past medical history was significant for morbid
obesity. Outpatient medications included the acetazolamide, acetaminophen as needed for pain,
and a prenatal vitamin. She had no known drug allergies. Pertinent lab values for the procedure
included hemoglobin of 12.1 grams per deciliter (g/dL), hematocrit 37%, and a platelet count of
191,000 per microliter (mcL).
Her physical assessment revealed a regular heart rate and rhythm and her lungs were
clear to auscultation. She denied chest discomfort or shortness of breath with activity. An
airway assessment revealed full dentition, full neck ROM, a thyromental distance of greater than
three fingerbreadths, an inter-incisor distance of fewer than three fingerbreadths, and a
Mallampati II airway. She did complain of uncontrolled reflux symptoms. She was NPO for
greater than 8 hours. Pre-operative vital signs included blood pressure 130/70 mmHg,
temperature of 36.0 degrees Celsius, heart rate 90/minute, respiratory rate 18/minute, oxygen
saturation 98% on room air. She was assessed an American Society of Anesthesiologists (ASA)
physical classification status three.
Upon transport to the operating room, the patient had a 1-liter (L) bag of lactated ringers
infusing through a 20-gauge intravenous (IV) catheter placed in the left wrist. An IV fluid bolus
was begun in pre-operative holding and continued throughout the transport. Upon arrival to the
operating room, the patient assumed a sitting position on the operating room (OR) table. A
blood pressure cuff, 5 lead electrocardiogram (EKG), and an oxygen saturation monitor were
applied to the patient. Pre-procedure vitals included heart rate of 75/min., respirations 16/min.,
blood pressure 125/84 mmHg on the right arm, and oxygen saturation of 99% on room air. After
sterile preparation of the lumbar spine for infection prevention, three milliliters (mL) of lidocaine
1% was injected subcutaneously in the L2-L3 interspace to provide local anesthesia for
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placement of the introducer. A 1 3/8 inch 20-gauge introducer was seated in the ligamentum
flavum at the level of the L2-L3 interspace. A 25-gauge spinal needle was advanced through the
introducer into the intrathecal space. Upon removal of the stylet, free-flowing CSF was
confirmed. The medication syringe was attached, and a small amount of CSF was aspirated.
After aspiration of CSF, 1.2 mL of 0.75% bupivacaine with 8.25% dextrose, 25 mcg of fentanyl,
and 0.3 mg of preservative-free morphine was slowly injected into the intrathecal space. After
withdrawal of the spinal needle and introducer simultaneously, the patient was placed in supine
position with left uterine displacement. She denied changes to her mild headache and/or visual
changes after the spinal injection.
Once she was assisted into surgical position, a nasal cannula (NC) with end-tidal CO2
(EtCO2) monitoring was placed on the patient with 3 liters of oxygen per minute flowing. A
non-invasive temperature probe was placed in the right axilla. Vital signs were reassessed
revealing blood pressure 112/60 mmHg, heart rate 94/minute, respiratory rate 18/minute, oxygen
saturation 100% on 3L per NC. The patient also complained of nausea associated with the
hypotension. She was treated with phenylephrine 100 mcg IV while the IV fluid bolus was
continued. Ondansetron 4 mg was administered IV push for treatment of her nausea. Upon
reassessment, her blood pressure was 108/54 mmHg and heart rate 100/min, an additional
phenylephrine 100 mcg IV was administered. Another dose of phenylephrine 100 mcg IV and
ephedrine 5mg IV was given after obtaining a blood pressure of 105/61 mmHg and a heart rate
of 72/min. Additionally, Ephedrine 10 mg IV was administered for a blood pressure of 115/64
mmHg and a heart rate of 65/min. Finally, the patient required one last dose of ephedrine 5 mg
IV three minutes later for a blood pressure of 120/70 mmHg and a heart rate of 70/min. The
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patient reported relief of her nausea with improvement of blood pressure and administration of
ondansetron.
Upon assessment of the spinal anesthetic, it was determined that the patient had achieved
a T6 level of anesthesia from the spinal administration. After preparation of the abdomen by
nursing staff, a sterile drape was placed. Prior to skin incision, the patient received 2 grams of
cefazolin via IV push. At the time of incision, vital signs were blood pressure 130/75 mmHg,
temperature of 36.1 degrees Celsius, heart rate 80/minute, respiratory rate 18/minute, oxygen
saturation 100% on 3 L per NC. Twenty-one minutes after placement of the spinal a viable baby
girl was delivered. The placenta was delivered two minutes later and an infusion of 0.9% normal
saline with 20 units of oxytocin was initiated.
Upon completion of the procedure by the surgeon, the patient was transported to the postanesthesia care unit (PACU) via a stretcher. She continued to deny headache and visual changes.
Assessment of sensation indicated that the patient had blockade of sensation to the T7
dermatome and was able to wiggle her toes. Intraoperatively, she received 2,700 mL of
crystalloid IV solution. Blood and amniotic fluid lost during the procedure totaled 800 mL.
Urine output for the case was 75 mL of clear yellow urine. Her stay in PACU was uneventful
and she was transferred to the inpatient ward. The patient and her baby were discharged home
three days later and she complained of only intermittent minor headache pain and surgical site
pain.
Literature Review
To guide the search for literature and define the required search terms, a PICO question
was created. A PICO question clarifies the search in terms of the population being studied (P),
the intervention in question (I), the group/treatment to which the intervention is being compared
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(C), and the outcome of the intervention (O) (Boswell & Cannon, 2014). This is done with the
goal of accurately guiding the literature search by helping to eliminate extraneous material. In
this format, the following PICO question was created for the anesthetic management of the
parturient with idiopathic intracranial hypertension. In parturients with idiopathic intracranial
hypertension (P), is neuraxial anesthesia (I) a safe option for management of vaginal or cesarean
delivery (O) when compared to general anesthesia (C)?
Databases
A literature search was conducted through several databases available through the UND
Health Sciences Library at the University of North Dakota. Through the Library, a search was
conducted through the Cochrane Library, PubMed, CINAHL, and SCOPUS databases. The
benefit of using these databases is the ability to access scholarly, peer-reviewed materials on the
topic of interest. With the availability of information resulted from internet search engines, there
is a significant amount of literature that contains personal opinion blogs, forums of discussion,
and advertisements that are filled with biased information. Use of a reputable library database
will help to improve the quality and reliability of results obtained from a literature search.
The PubMed database was accessed and medical subject headings (MeSH) were utilized
to access articles. MeSH terms offer a controlled vocabulary thesaurus as a way to index terms
and more effectively search MEDLINE, which is the largest database within PubMed (Richter &
Austin, 2012). Although the condition is currently referred to as idiopathic intracranial
hypertension, it was previously called pseudotumor cerebri due to the way symptoms suggested
an intracranial tumor. When the term “idiopathic intracranial hypertension” is entered into a
MeSH database, it suggests the MeSH term “pseudotumor cerebri”. Pseudotumor cerebri was
added to the search builder with the Boolean operator “AND” inserted after the term. Anesthesia
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was also entered into the MeSH search bar resulting in thirty-four options. From this list, spinal
anesthesia, epidural anesthesia, and general anesthesia were selected and added to the search
builder. The Boolean operator between each anesthesia option was “OR”. “Search PubMed”
button was selected. Twenty-one articles resulted from the search. Seven articles were relevant
to the search, but four were selected due to the age of some of the articles.
The Cochrane library is a collection of several databases that contain high-quality
evidence to inform evidence-based practice in the healthcare setting. Two of these databases are
the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled
Trials (Cochranelibrary.com, 2018). These databases hold some of the highest levels of
evidence available concerning healthcare related topics. Upon arriving to the Cochrane Library
page, “Advanced Search” was selected. The Medical Terms (MeSH) tab was selected.
Pseudotumor cerebri was searched and the button “Add to Search Manager” was selected. In the
second search bar of the search manager, search terms of spinal anesthesia and epidural
anesthesia were entered with the Boolean operator “OR” placed between them. When a search
was conducted with these terms, only one result was found that was not applicable to this topic.
When the MeSH term “pseudotumor cerebri” was searched alone, thirty-six results populated.
None of the results were applicable to the topic of anesthetic management of the parturient.
Next, the CINAHL database was used. CINAHL is the Cumulative Index to Nursing and
Allied Health Literature and utilized for access to many nursing journals for study. A total of
four searches were conducted on CINAHL. Terms used for the first search included idiopathic
intracranial hypertension and anesthesia. This resulted in one article that was a duplicate from
the PubMed search. Idiopathic intracranial hypertension was then searched with the term
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pregnancy. This search resulted in 12 articles. Five of the articles applied to the topic with two
of the articles being duplicate articles from the PubMed search.
Additional CINAHL searches were conducted with the term pseudotumor cerebri due to
the popularity of the term in PubMed searches even though the correct term is now idiopathic
intracranial hypertension. When combined with the term anesthesia, no articles were resulted.
Using the term pseudotumor cerebri in combination with the term pregnancy also resulted in zero
articles.
Utilizing the SCOPUS database, a search was conducted for idiopathic intracranial
hypertension and anesthesia. The search resulted in thirty-nine articles. Limiters placed on the
search included: publishing date of 2009-2018, English language, and articles and reviews only.
These limiters resulted in twenty-one articles. Four of these articles were applicable to the topic,
but two of them were duplicate articles.
In addition to these articles retrieved from the above databases, three articles were
discovered through the review of bibliographies of the reputable articles that were found in the
above literature search.
Review of Literature
In order to understand the anesthetic considerations for a parturient with IIH, it is
important to first understand components of intracranial pressure, neuraxial anesthesia, as well as
the diagnosis and pathophysiology of the disease. With the understanding of these key aspects,
we can then begin to discuss the anesthetic considerations for this pathology within such a
common patient population in anesthetic practice. The review of literature will progress through
these topics accordingly.
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Components of Intracranial Pressure
The rigid skull contains three components that make intracranial pressure. These three
contents are brain tissue, blood, and cerebral spinal fluid (CSF) (Nagelhout & Plaus, 2014). Due
to the rigidity of the skull, the volume contained in the skull must remain in a fixed, but regulated
volume to prevent an increase or decrease of intracranial pressure (ICP) (Butterworth, Mackey,
& Wasnick, 2013). The Monro-Kellie doctrine governs this regulation stating that any
expansion in volume of tissue, blood, or CSF will result in a reduction in blood or CSF volume
to compensate and reduce ICP (Leffert & Schwamm, 2013). Although small increases in ICP
are well tolerated, problems may rise when pressure continues to rise (Leffert & Schwamm,
2013). When pressures continue to rise beyond what the contents can compensate for, untoward
neurological sequelae can result with the end result of which is brain herniation (Butterworth et
al., 2013; Nagelhout & Plaus, 2014; Oropello, Pastores, & Kvetan, 2017). According to
Butterworth et al. (2013), compensatory mechanisms that adjust for increasing ICP include
displacement of CSF out of the cranial vault into the spinal compartment, increased CSF
absorption, decreased CSF production, and a decrease in cerebral blood volume.
Brain tissue makes up 80% of the total volume of intracranial contents (Butterworth et
al., 2013). Brain tissue is minimally compressible and cannot be altered to accommodate
increasing ICP (Leffert & Schwamm, 2013). Brain tissue can contribute to increasing
intracranial volume and, therefore, contribute to increasing ICP, but it is not a contributor to the
compensatory mechanisms to reduce ICP (Leffert & Schwamm, 2013). Cerebral edema can
result from traumatic or atraumatic sources (Butterworth et al., 2013). Atraumatic sources of
cerebral edema include tumors, electrolyte imbalances, infection, or ischemia (Butterworth et al.,
2013). Traumatic injuries to the head can result in an inflammatory process that increases the
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amount of brain tissue in the rigid cranial vault (Hines & Marschall, 2012). Hines and Marschall
(2012) go on to state that although there are medical interventions that can be attempted to
reduce cerebral edema, the brain tissue does not have an ability to compensate for increasing
ICP. Rather, it is dependent on CSF and cerebral blood flow compensation to reduce ICP to
avoid neurological damage (Hines & Marschall, 2012).
Cerebral blood volume is the second component of intracranial contents and pressure and
is able to compensate for increasing ICP (Butterworth et al., 2013; Nagelhout & Plaus, 2014;
Leffert & Schwamm, 2013). Cerebral blood flow (CBF) plays a crucial role in providing brain
tissue with oxygen, glucose, electrolytes, amino acids, and removal of metabolic waste products
(Butterworth et al., 2013). Cerebral blood volume is approximately 150 mLs of fluid at any
given time and influenced by the local tissue needs and arterial partial pressure of carbon dioxide
(Butterworth et al., 2013; Nagelhout & Plaus, 2014; Leffert & Schwamm, 2013). Vasogenic
edema, vessel rupture, and venous occlusion can all lead to an increase in ICP through the
leakage of intravascular contents into the brain tissue (Anson, Vaida, Giampetro, & McQuillan,
2015). These pathologic processes will also increase ICP by preventing the free flow of CSF in
the ventricles (Leffert & Schwamm, 2013). Cerebral blood flow is determined by five factors:
cerebral metabolic rate for oxygen, cerebral perfusion pressure, venous pressure, the partial
pressure of carbon dioxide (PaCO2), and the partial pressure of oxygen (PaO2) (Hines &
Marschall, 2012). Although it may contribute to increasing ICP, cerebral blood volume is an
important component of the compensatory mechanisms that control a rising ICP (Hines &
Marschall, 2012).
Nagelhout and Plaus (2014) describe the secretion, absorption, and roles that CSF plays
in the nervous system. They state that CSF flows in the subarachnoid space in the brain and
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spinal cord and plays an important role cushioning the brain, providing buoyancy, and promoting
optimal conditions for brain function (Nagelhout & Plaus, 2014). In a normal healthy adult,
there is approximately 150 mL of CSF circulating at any given time (Nagelhout & Plaus, 2014).
Nagelhout and Plaus (2014) continue to state that CSF is produced by the ependymal cells of the
Choroid Plexus, which is located in the Lateral, Third, and Fourth Ventricles at a rate of 20-30
mL/hr for a total of 400-500 mL of new CSF daily. CSF pressure, which is also known as ICP is
between 5 and 15 mm Hg (Butterworth et al., 2013; Hines & Marchall, 2012; Leffert &
Schwamm, 2013; Nagelhout & Plaus, 2014). Nagelhout and Plaus (2014) describes the flow of
CSF from its place of creation to its place of absorption. They describe that CSF created in the
Left and Right Lateral Ventricles will flow through the Foramen of Monro into the Third
Ventricle where it is also produced. From the Third Ventricle, CSF continues through the
Aqueduct of Sylvius into the Fourth Ventricle, which is another site of CSF production. From
this point, CSF can flow through the Foramen of Luschka and Foramen of Magendie into the
Subarachnoid Space of the brain and spinal cord. It circulates through to the Superior Sagittal
Sinus where it is absorbed at the Arachnoid Villi at a rate that should be similar to the rate of
production (20-30 mL/hr) (Nagelhout & Plaus, 2014). Reabsorption of CSF is dependent on the
pressure gradient that exists between CSF and the venous system (Hines & Marschall, 2013).
The Arachnoid Villi will empty into the intracranial venous sinuses, which are non-compressible
venous networks incorporated into the skull (Butterworth et al., 2013).
According to Leffert and Schwamm (2013), problems can occur if there is obstruction of
the flow of CSF or a mismatch of production and absorption of CSF. They go on to describe a
situation when the free flow of CSF is obstructed between ventricles, the spinal cord, and the site
of absorption in the Superior Sagittal Sinus resulting in a condition called Communicating
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Hydrocephalus. If this condition occurs quickly, symptoms can be seen in minutes to hours,
whereas a partial obstruction will occur over days to weeks and may be better tolerated (Leffert
& Schwamm, 2013).
In the bony skull, the volume of total contents remains relatively constant because any
increase in one factor will result in the decrease in volume of another factor (Anson et al., 2015).
Intracranial compliance is defined as the change in volume for a change in pressure (Anson et al.,
2015). Because the rigid skull does not change, the intracranial compliance curve is a result of
the three elements of brain tissue, blood volume, and CSF (Anson et al., 2013; Butterworth et al.,
2013; Hines & Marschall, 2012; Leffert & Schwamm, 2013). Brain tissue contributes to a steep
section of the curve due to its non-compressibility, but the initial slope of the curve is more
flattened because of the ability of blood and CSF being shunted to extracranial reservoirs when
brain tissue volume increases (Leffert & Schwamm, 2013). After reaching a certain point, CSF
and blood volume will contribute to rising ICP after compensatory measures have exceeded their
ability to shunt fluids elsewhere to those reservoirs (Anson et al., 2015; Leffert & Schwamm,
2013). Once this ability to shunt and compensate is exhausted, small increases in intracranial
volume from any of the three contributing factors will result in steep increases in ICP and the
damage that accompanies it (Anson et al., 2015; Leffert & Schwamm, 2013).
Idiopathic Intracranial Hypertension
Idiopathic Intracranial Hypertension (IIH) was first described in 1897 by Quincke in a
condition he described as “serous meningitis” (Worrell & Lane, 2007). The condition has been
known by several names throughout the last century from serous meningitis, pseudotumor
cerebri, benign intracranial hypertension, and finally, idiopathic intracranial hypertension
(Worrell & Lane, 2007). IIH affects more females at a ratio of 8:1 (Evans & Lee, 2010). In the
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general population, it occurs at a rate of one in 100,000 with obese women in their child-bearing
years being at highest risk at a rate of one in 5,000 (Evans & Lee, 2010; Karmaniolou et al.,
2011; Kesler & Kupferminc, 2013; Worrell & Lane, 2007). It is likely that anesthesia providers
may see an increase in occurrence of the disease as the obesity problem continues to worsen
(Moore et al., 2014). As the role of anesthesia assistance with analgesia during labor and
delivery has increased, it becomes increasingly important to understand the implications of this
intracranial pathology in order to provide a safe anesthetic to this patient population.
Evans and Lee (2010) state that 90% of patients with undiagnosed IIH will present with a
headache. They continue to describe that the headache is reportedly worse in the morning with
associated photophobia. Patients often report visual changes, as well as back, neck and shoulder
pain (Karmaniolou et al., 2011). Up to 60% of cases have complained of nausea, vomiting, and
even pulsatile tinnitus (Kesler & Kupferminc, 2013). Visual disturbance is the second most
commonly reported complication of the disease process (Evans & Lee, 2010). Disturbances are
characterized by visual field loss, loss of acuity, and double vision related to sixth cranial nerve
palsy (Karmaniolou et al., 2011; Kesler & Kupferminc, 2013). Unfortunately, 10-20% of all
patients with IIH will develop vision loss (Kesler & Kupferminc, 2013). The most telling sign of
IIH is bilateral papilledema, but rarely, this may be absent or occur unilaterally (Karmaniolou et
al., 2011). Papilledema is the result of bulging on the optic disc in the retina from increased ICP
(Worrell & Lane, 2007). Although rare, IIH can progress to cause complete visual loss in
patients that do not seek treatment (Evan & Lee, 2010; Karmaniolou et al., 2011; Kesler &
Kupferminc, 2013; Worrell & Lane, 2007).
IIH is described as a condition that has no known cause (Karmaniolou et al., 2011). It is
characterized by increased CSF pressure that creates an ICP of greater than 20 mmHg with
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normal CSF composition and negative imaging for intracranial pathology (Karmaniolou et al.,
2011; Kesler & Kupferminc, 2013). Although there have been no definitive discoveries of an
etiology, several theories have been proposed for the origin of elevated CSF pressure including
excessive production of CSF, a reduction in CSF absorption, or an increase in cerebral venous
sinus pressure (Anson et al., 2015; Karmaniolou et al., 2011; Kesler & Kupferminc, 2013;
Worrell & Lane, 2007). Kesler and Kupferminc (2013) suggest that any theory that is proposed
needs to account for the fact that IIH particularly effects obese women and should consider that
hormones play a role in the cause of the disease.
According to Karmaniolou et al. (2011), diagnosis of IIH after a patient presents with
signs and symptoms is essentially a diagnosis of exclusion. They continue to state that the
assessment should be based on modified Dandy criteria for the diagnosis of IIH includes seven
specific criteria:
Symptoms of raised intracranial pressure, no localizing signs with the exception of
sixth nerve palsy, CSF pressure of 25 mmHg or greater measured in the lateral
decubitus position, normal CSF composition, patient awake and alert, normal
neuroimaging studies without evidence of thrombosis, except for an empty sella,
and no other explanation for the raised intracranial pressure. (p. 652)
Neuroimaging should be completed first to rule out intracranial space occupying lesions and
assess for high CSF pressure (Anson et al., 2015; Karmaniolou et al., 2011; Kesler &
Kupferminc, 2013). Magnetic resonance imaging (MRI) is the gold standard for imaging, but it
is important to remember that contrast dye should be avoided in the parturient (Anson et al.,
2015).
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Kesler and Kupferminc (2013) provide a great run down on common differential
diagnoses for patients that present with these symptoms during pregnancy. They describe the
most common differential diagnosis includes venous thrombosis. They state that a dural venous
thrombosis will behave very similar to IIH with symptoms of headache and papilledema (Kesler
& Kupferminc, 2013). Nagelhout and Plaus (2014) describe the physiologic changes that
predispose pregnant women to thrombosis. Although most of the coagulation factors are
increased, hypercoagulability is predominantly related to increased levels of factor VII, VIII, IX,
X, and fibrinogen (Nagelhout & Plaus, 2014). Venous thrombus can be ruled out with either a
MRI or computed tomography venogram (Kesler & Kupferminc, 2013). Other differential
diagnoses without a space occupying lesion include: anemia, certain medications (tetracycline,
minocycline, doxycycline, nalidixic acid, nitrofurantoin, lithium, vitamin A, leuprolide acetate,
stanozol, or growth hormone), meningitis (which would be excluded with normal CSF studies),
hypoparathyroidism, and uremia (Kesler & Kupferminc, 2013).
IIH can range from uncomfortable head and neck pain to debilitating vision loss (Evans
& Lee, 2010; Karmaniolou et al., 2011). Kesler and Kupferminc (2013) emphasize that it is
crucial that the parturient is treated timely and managed appropriately to avoid progression of the
disease. Kesler and Kupferminc (2013) state that the treatment of IIH can utilize medical and
surgical approaches depending on the severity and the patient’s response to treatment. Treatment
is aimed at decreasing the production of CSF or displacing CSF from the subarachnoid space
with a goal of symptom control and vision preservation (Kesler & Kupferminc, 2013).
A medically managed approach for IIH should include the management of weight,
utilization of medications that reduce inflammation and production of CSF but may also include
serial lumbar punctures to drain excess CSF (Month & Vaida, 2012; Karmaniolou et al., 2011;
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Kesler & Kupferminc, 2013). The most common approach to medical management of IIH is
scheduled acetazolamide (Month & Vaida, 2012; Kesler & Kupferminc, 2013; Karmaniolou et
al., 2011). According to Karmaniolou et al. (2011), acetazolamide is a carbonic anhydrase
inhibitor that is employed as a diuretic to decrease CSF production. They continue to discuss the
fact that although the FDA has designated this a category C medication (showing adverse effects
in animal studies), it has been used successfully to manage IIH. Long term use of acetazolamide
is associated with acidemia (Month & Vaida, 2012). Medication regimens to reduce
inflammation may be employed and would involve the use of corticosteroids (Kesler &
Kupferminc, 2013; Month & Vaida, 2012). Month and Vaida (2012), state that further medical
management may employ single or serial lumbar punctures to drain excessive CSF. Month and
Vaida (2012) suggest removing 20-40 mL of CSF with lumbar punctures as symptoms appear
despite non-invasive management. Karmaniolou et al. (2011) suggests utilizing an approach that
drains CSF until the CSF pressure is less than 20 mmHg for symptom control.
Kesler & Kupferminc (2013) reveal that when medical therapy fails to control symptoms
and disease progression, surgical intervention should be considered. They clarify this by saying
that surgical intervention is typically reserved for patients in which severe or progressive visual
loss is present. Optic nerve sheath fenestration (ONSF), lumboperitoneal (LP) shunts, or
ventriculoperitoneal (VP) shunts can control the pressure on a continual basis to optimize ICP
(Karmaniolou et al., 2011). LP or VP shunt placement has failed in approximately 50% of cases
due to the gravid uterus and is preferably avoided (Karmaniolou et al., 2011; Kesler &
Kupferminc, 2013). ONSF is ideally used to relieve pressure in the optic nerve sheath by
creating a small window to drain fluid from the peri-optic subarachnoid space into the
retrobulbar space (Kesler & Kupferminc, 2013). Kesler and Kupferminc (2013) elaborate that
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this approach specifically protects against vision loss by relieving pressure on the optic nerve and
results in lower morbidity than does shunt placement. Again, surgical intervention is reserved
for individuals in which medical therapy has failed due to risks associated with surgical
intervention in the parturient (Karmaniolou et al., 2011; Kesler & Kupferminc, 2013).
Anesthetic considerations for the parturient with IIH
Providing analgesia for labor and delivery in the parturient with IIH requires careful
planning, review of the patient’s history and management of their condition, as well as
understanding of the disease pathology. In a healthy parturient, fluctuations in the intracranial
contents due to the physiologic changes during labor and delivery are small enough to avoid
complications associated with a sharp rise in ICP (Anson et al., 2015). In the parturient with IIH,
the elevated CSF pressure has potential to disrupt the pressure/volume balance and may result in
substantial increases in ICP and vision loss in the parturient (Leffert & Schwamm, 2013). With
this being said, IIH is not a specific indication for cesarean delivery and patients can attempt and
undergo vaginal deliveries (Evans & Lee, 2010; Karmaniolou et al., 2011; Kesler & Kupferminc,
2013; Leffert & Schwamm, 2013). Uterine contractions and “pushing” associated with labor
increases blood pressure, cardiac output, central venous pressure (CVP), and, as a result, will
increase CSF pressure (Evans & Lee, 2010; Leffert & Schwamm, 2013). Although Kesler and
Kupferminc (2013) indicate that a patient with IIH is not necessarily at high risk for visual loss,
the patient must still be monitored throughout the laboring process to assess for neurologic and
ocular complications.
Neuraxial anesthesia is the preferred route of anesthesia for the parturient due to the
ability of the mother to be awake for the birth of her child and minimal effects to the fetus when
compared to general anesthesia (Nagelhout & Plaus, 2014). General anesthesia can also mask
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neurologic symptoms if complications occur in the parturient with IIH (Karmaniolou et al.,
2011). With this being said, it is important to consider the effects of neuraxial anesthetics on
ICP when treating a patient with pre-existing elevated ICP (Leffert & Schwamm, 2013).
Epidural administration for patients with IIH is acceptable with certain considerations (Anson et
al., 2015; Karmaniolou et al., 2011; Leffert & Schwamm, 2013). Injection of medications into
the epidural space may translate that increase in pressure into the intrathecal space (Anson et al.,
2015; Karmaniolou et al., 2011; Leffert & Schwamm, 2013). Leffert and Schwamm (2013) state
that increased pressure is translated upward into the cranium putting the patient at risk for
morbidity. They continue to explain that increased ICP at baseline results in a more pronounced
rise in ICP after epidural injection than those with normal ICP (Leffert & Schwamm, 2013).
This pressure increase may vary with volume of injection and baseline ICP levels (Anson et al.,
2015; Karmaniolou et al., 2011).
Another complication associated with epidural anesthetics is accidental dural puncture
(Moore et al., 2014; Nagelhout & Plaus, 2014). Loss of CSF caused by accidental dural puncture
is typically well tolerated in patients with IIH due to the excess amount of CSF produced (Moore
et al., 2014). Therefore, occurrence of post-dural puncture headache (PDPH) is extremely low in
IIH patients (Month & Vaida, 2012; Moore et al., 2014). Also, patients with IIH are not at risk
for herniation related to rapid loss of CSF from dural puncture like other patient populations with
increased ICP (Leffert & Schwamm, 2013). It is suggested that if epidural anesthesia is utilized,
the medication should be administered through a slow infusion, rather than a bolus of
medications to reduce the likelihood that rapid injection in the epidural space would translate to
higher intracranial pressures (Anson et al., 2015; Karmaniolou et al., 2011; Leffert & Schwamm,
2013). Leffert and Schwamm (2013) suggest incremental dosing in the range of 5 mL every 5-7
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minutes to avoid elevation of ICP. Additionally, when choosing epidural anesthesia, it is
important to consider the possibility for emergent cesarean section delivery if complications
occur and sequelae that could result from the need to bolus medications through the epidural
catheter (Leffert & Schwamm, 2013).
Although spinal anesthetics are contraindicated in patients with increased ICP related to a
space occupying lesion, it is not contraindicated in patients with IIH (Leffert & Schwamm,
2013). Spinal anesthetics can be used with success in patients with IIH, but care must be
exercised as any volume added to the intrathecal space has the potential to be translated upward
toward the cranium causing complications (Anson et al., 2015; Karmaniolou et al., 2011; Leffert
& Schwamm, 2013). There have been several approaches described in the literature ranging
from single shot injections to continuous intrathecal catheters that are also used as pressure
monitors and therapeutic drains (Aly & Lawther, 2007; Anson et al., 2015; Karmaniolou et al.,
2011; Kesler & Kupferminc, 2013; Moore et al., 2014). Further considerations exist for those
with implanted lumboperitoneal shunts (Karmaniolou et al., 2011; Kesler & Kupferminc, 2013).
Spinal anesthetic variations for the parturient with IIH
For single shot spinal anesthetics, Month and Vaida (2012) suggest using a small
atraumatic needle. They continue to describe the withdrawal of CSF prior to any injection to
treat IIH symptoms (Month & Vaida, 2012). Month and Vaida (2012) also suggest using the
smallest injectate volume possible to reduce the likelihood that increased pressure would be
associated with the injection. At this time, we recall how important it is to obtain patient history
anesthetic planning for all patients. For parturients with IIH, it is crucial that the anesthetist
understands how the patient has been managed prior to administration of spinal anesthetics
(Kesler & Kupferminc, 2013). A patient that has been treated aggressively with diuretics or
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serial lumbar punctures may be deficient of adequate CSF volume (Karmaniolou et al., 2011).
Butterworth et al. (2013) reveal that dermatomal spread is greater in patients with a small volume
of CSF. This could result in a high or even a total spinal (Karmaniolou et al., 2011).
A commonly described technique involves the use of an indwelling intrathecal catheter
(Aly & Lawther, 2007; Karmaniolou et al., 2011, Moore et al., 2014). Karmaniolou et al. (2011)
and Moore et al. (2014) described using the intrathecal catheter with success on patients laboring
with eventual vaginal deliveries. Aly and Lawther (2007) describe a case in which the
intrathecal catheter was utilized successfully for a parturient undergoing elective cesarean
section delivery. The advantage to the intrathecal catheter is three-fold (Aly & Lawther, 2007
Karmaniolou et al., 2011; Moore et al., 2014). First, the use of an intrathecal catheter will allow
the anesthetist to continuously provide labor analgesia to the patient. Second, the indwelling
catheter will allow for the continuous monitoring of CSF pressure throughout the laboring
process. Finally, if intervention is required for elevated CSF pressures or neurological decline
associated with the laboring process, the indwelling catheter can be used as a therapeutic drain
(Aly & Lawther, 2007; Karmaniolou et al., 2011; Moore et al., 2014). More research is needed
regarding parameters of CSF monitoring and indications on when intervention is necessary.
Moore et al. (2014) reported CSF pressures during the second stage of labor fluctuating between
25 and 27 mm Hg at rest and peaking at 60 mm Hg when pushing. None of the literature
discussed a suggested volume to remove or target CSF pressure if intervention was needed for
elevated CSF pressures or neurological symptoms occurring while the intrathecal catheter was in
place. Although the use of an intrathecal catheter in the general population is associated with an
increased risk of PDPH, the occurrence of PDPH in parturients with IIH is extremely low
(Month & Vaida, 2012; Moore et al., 2014).
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Month and Vaida (2012) described a combined spinal epidural (CSE) approach in two
patients in which they slowly removed 5 mL of CSF prior to sub-arachnoid injection of
anesthetics. This removal of fluid greatly improved patient symptoms with both patients
reporting a significant reduction in headache pain (Month & Vaida, 2012). After the removal of
fluid, an intrathecal injection of fentanyl 10 mcg was placed as was their practice for early labor,
followed by placement of an epidural infusion catheter for continued analgesia during labor
(Month & Vaida, 2012). After intrathecal injection, Month and Vaida (2012) reported placement
of an epidural catheter with a slow epidural infusion of 0.125% bupivacaine and fentanyl 2
mcg/mL at a rate of 6 mL/hr. According to Month and Vaida (2012), the advantage to this
approach includes the reduction in CSF volume and pressure with the removal of CSF prior to
intrathecal injection. With the intrathecal injection, an epidural bolus was not required, rather a
slow infusion was initiated for ongoing analgesia avoiding a sharp increase in CSF pressure
associated with epidural bolus (Month & Vaida, 2012).
The previous paragraphs have discussed anesthetic considerations for the patient with IIH
that has had symptoms controlled medically. Special considerations should be taken for patients
with IIH whose condition is controlled with a surgical intervention. As previously mentioned,
IIH patients with neurologic symptoms that cannot be controlled with medical management may
be treated surgically with optic nerve sheath fenestration or a lumboperitoneal shunt
(Karmaniolou et al., 2011; Kesler & Kupferminc, 2013). Neuraxial anesthesia administration for
patients with an LP shunt is controversial for several reasons (Anson et al., 2015; Karmaniolou et
al., 2011; Kesler & Kupferminc, 2013). Patients with LP shunts can be at risk for infection of
the device and ineffective anesthetic administration (Anson et al., 2015; Kesler & Kupferminc,
2013). It is believed that intrathecal injection of local anesthetic may be redirected into the
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peritoneal space through the shunt resulting in poor anesthetic coverage (Karmaniolou et al.,
2011; Kesler & Kupferminc, 2013). For this reason, Kesler and Kupferminc (2013) suggest
general anesthesia for cesarean section despite the many risks associated with it. Although
Anson et al. (2015) acknowledge the risk of damage or infection to a LP shunt with neuraxial
anesthesia, they report safe anesthetics being administered through epidural administration.
They elaborate further by saying that epidural injections can be done successfully if administered
in another interspace from the shunt and radiographic imaging should be considered for
placement in the correct interspace (Anson et al., 2015). Additionally, Karmaniolou et al. (2011)
discuss the theoretical risk of infection of a shunt with introduction of a catheter, but do not
advocate the use or disuse of prophylactic antibiotics. Finally, concerning removal of the
epidural catheter, it is important to take care removing the epidural catheter due to the theoretical
risk of entanglement of the catheter with the shunt (Karmaniolou et al., 2011). They suggest
imaging studies be conducted if abnormal resistance is noted while removing the catheter (Anson
et al., 2015; Karmaniolou et al., 2011).
Discussion
The patient in this case review was a primiparous female with a new diagnosis of IIH
during her pregnancy. She was diagnosed and treated medically with one diagnostic and one
therapeutic lumbar puncture and scheduled acetazolamide. She complained of a headache but
denied visual changes with the condition. She presented for an elective cesarean delivery for a
baby in the breech position. Based on her current symptomology and her medical management
throughout her pregnancy, it was determined that a small volume single shot intrathecal injection
should be used to provide anesthesia for her cesarean delivery. Spinal anesthesia is not
contraindicated in patients with elevated ICP due to IIH. Anesthetic management during the
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cesarean section coincides with evidence that is discussed in the literature. During the procedure
the patient denied worsening of her headache or development of visual changes.
Conclusion
IIH is a neurologic condition of unknown origin with the highest rate of occurrence in
obese women of child-bearing age (Month & Vaida, 2012). Typically, patients present to
primary care with vague symptoms of elevated ICP. The diagnosis of IIH is a diagnosis of
exclusion using Modified Dandy Criteria (Karmaniolou et al., 2011). Although symptoms
commonly involve head and neck pain, IIH can progress to cause neurologic complications
including vision loss. The condition may be treated medically using steroids, carbonic anhydrase
inhibitor diuretics, and/or serial lumbar punctures. Patients that do not respond to medical
therapy may require surgical intervention with placement of lumboperitoneal shunts or optic
nerve sheath fenestration to prevent vision loss.
IIH is an uncommon condition with a high risk of morbidity if there is poor anesthetic
planning. With proper management the patient may be allowed to labor and undergo vaginal or
cesarean delivery. Epidural anesthetics should be administered carefully, and boluses should be
avoided making this an unwise choice with the risk of any labor course requiring an emergent
cesarean delivery. Spinal anesthetics can be employed if there is no LP shunt present. Use of an
intrathecal catheter is beneficial for the administration of medications, monitoring of CSF
pressures, and treatment of therapeutic removal of CSF if neurologic condition deteriorates.
With the presence of an LP shunt, epidural anesthesia is possible with care exercised for correct
interspace placement and removal of the catheter to avoid damaging of the shunt. Although
there is a fair amount of research on the medical management of IIH, research on the anesthetic
implications for patients with the condition is fairly limited. No national guidelines exist for
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obstetrical care of the parturient with IIH. Further research is required to produce a consistent
guide for treatment in this patient population.
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Appendix A

Anesthesia in Labor and Delivery
Anesthetic Considerations for the
Parturient with
Idiopathic Intracranial Hypertension
Levi La Porte, SRNA

• Over 4 million births per year in the U.S.
• 32% of all births come through cesarean section
• Approximately 61% of all parturients receive
spinal or epidural anesthetics to aid with the
delivery process
• Although women of child‐bearing years are
typically healthy, comorbidities may exist that
require consideration for proper anesthetic
planning
(Martin, Hamilton, Osterman, Driscoll, & Matthews, 2017; Osterman & Martin, 2011)

Idiopathic Intracranial Hypertension

Idiopathic Intracranial Hypertension

• Described in 1897 by Quincke
• Unknown cause
• Increased ICP in the presence of negative neuroimaging and
negative CSF studies. Increased CSF volume present
• Has been known as: serous meningitis, pseudotumor cerebri,
benign intracranial hypertension, and idiopathic intracranial
hypertension (IIH)
• Occurrence: 1:100,000 in general population, but 1:5,000 in obese
women of child‐bearing age
• Despite its rare occurrence, it carries important considerations for
neuraxial anesthesia that may result in permanent neurologic
damage if not planned for appropriately

SYMPTOMS
• Headache
– Worse in the morning
– Photophobia

•
•
•
•

Back, neck, shoulder pain
Nausea and vomiting
Pulsatile tinnitus
Visual disturbances
– Related to 6th cranial nerve compression
– 10‐20% of cases progress to visual loss
(Karmaniolou et al., 2011; Kesler & Kupferminc, 2013)

(Kesler & Kupferminc, 2013; Karmaniolou, Petropoulos, & Theodoraki, 2011; Month & Vaida, 2012)

Diagnosis of IIH

Idiopathic Intracranial Hypertension

Diagnosis made based on Modified Dandy Criteria with the
presence of:

Treatment:
• Medical Management

–
–
–
–

Patient is awake and alert
Symptoms of raised intracranial pressure
No localizing signs with the exception of sixth cranial nerve palsy
CSF pressure of 25 mmHg or greater in the lateral decubitus
position
– Normal CSF composition
– Normal imaging studies without evidence of thrombosis, except
for empty sella turcica
– No other explanation for the raised ICP
(Karmaniolou et al., 2011, pg. 652)

– Weight control
– Diuretics
• Acetazolamide

– Anti‐inflammatory drugs
• Corticosteroids

– Therapeutic lumbar punctures

• Surgical Management
– Lumboperitoneal Shunt
– Optic Nerve Sheath Fenestration

1
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Case Information

Pre‐operative Evaluation

• Primary cesarean section for fetal
presentation in breech position
• 21‐year‐old female
• 160 cm
• 155 kg
• ASA physical classification status: 3
• No known allergies

Past Surgical History
• Negative
Past Medical History
• Primigravida 37‐weeks gestation
• Morbid Obesity
• Idiopathic Intracranial Hypertension (IIH) [diagnosed
this pregnancy]
Outpatient Medications
• Acetazolamide QID
• Tylenol PRN
• Multi‐vitamin

32

Pre‐operative Evaluation
History of Present Illness
• Pregnancy course complicated with
neck/shoulder pain, ringing in the ears, dizziness,
nausea, vomiting, headache, and blurred vision
• Consulted by Neurology and Ophthalmology
– Neuroimaging and lumbar puncture were negative for
pathology
– Diagnosed with IIH with papilledema

Pre‐op Vitals:
TPR: 36.0, 90 bpm, 18/min
BP: 130/70 mmHg
SpO2: 98% on room air

Pertinent Lab Values:
Unremarkable
Hemoglobin: 12.1 g/dL
Hematocrit: 37%
Platelets: 191,000/mcL

• Managed with one therapeutic lumbar puncture
after diagnosis
• Maintained with acetazolamide QID

Airway Assessment:
Patient complained of a mild
• Mallampati III
• Inter‐incisor distance >3 headache, but denied visual
• Full dentition and neck disturbances in pre‐op
ROM
• Thyromental distance >3

Operative Course

Operative Course

• Anesthetic

• Twenty‐one minutes after placement of SAB a
viable baby girl was born
• Fluid Totals:

– Single shot subarachnoid block (SAB)
• 1.2 mL of 0.75% bupivacaine with 8.25% dextrose
• 20 mcg fentanyl
• 0.3 mg morphine

– Patient denied worsening of headache or visual changes with SAB
– T6 dermatome level sensory block achieved

• Additional Medications
–
–
–
–
–

Ondansetron 4 mg
Cefazolin 2 grams
Phenylephrine 100 mcg x 3 for hypotension
Ephedrine 5‐10 mg x 3 for hypotension
Oxytocin 20 units in 1 L Lactated Ringer’s IV solution

– 2700 mL crystalloid
– 800 mL blood and amniotic fluid loss
– 75 mL clear yellow urine

• The patient denied headache or visual
disturbance in PACU
• Patient and baby were discharged home on post‐
op day 3 denying visual disturbance and
complaining of only a minor headache

2
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Discussion

Cerebral Spinal Fluid

Components of Intracranial Pressure
• With the rigid skull, the volume must remain fixed, but
regulated to prevent an increase or decrease in ICP
• Three components: Brain Tissue, Blood, and CSF
• Monro‐Kellie Doctrine states that any increase in volume
(tissue, blood, or CSF) will result in reduction of blood or
CSF volume to maintain a relatively constant ICP
• Compensatory mechanisms for an increasing ICP:

CSF flows in the subarachnoid space to cushion and provide buoyancy
to the brain and promote optimal conditions for function

–
–
–
–

Displacement of CSF into spinal compartment
Increased CSF absorption
Decreased CSF production
Decreased cerebral blood volume
(Butterworth et al., 2013; Leffert & Schwamm, 2013; Oropello, Pastores, & Kvetan, 2017)

FLOW OF CSF:
• Produced in the ependymal cells of the
choroid plexus
• Left & right ventricles
• Foramen of Monro
• Third ventricle
• Aqueduct of Sylvius
• Fourth ventricle
• Foramen of Luschka & Magendie
• Subarachnoid space
• Superior sagittal sinus (site of
absorption at the arachnoid villi)

CSF stats:
• 150 mL total volume
• Produced at a rate of 20‐30 mL/hr
• 400‐500 mL of new CSF is produced and
absorbed daily
• Normal ICP 5‐15 mmHg

(Nagelhout & Plaus, 2014)

Idiopathic Intracranial Hypertension
Anesthetic Considerations

Idiopathic Intracranial Hypertension
Epidural

• Pre‐operative planning and understanding of how their
conditions were managed is crucial
• ICP fluctuates naturally with the labor and delivery process

• Pressure from an epidural bolus injection can be translated
into the intrathecal space & upward into the cranium
• Pressure increase varies with volume of injection &
baseline ICP levels
• Post‐dural puncture headache (PDPH) occurrence is very
low in IIH
• IIH patients are not at risk for tonsillar herniation with CSF
loss like with other conditions of increased ICP
• Incremental epidural dosing of 5 mL every 5‐7 minutes;
typical infusion rates used during labor are safe in IIH
• Remember the inability to bolus medication through the
epidural in case of emergent cesarean sections

– Uterine contractions and “pushing” increase central venous
pressure, cardiac output, blood pressure, and ICP

• Any sustained elevation in ICP could potentially cause visual
loss in the patient from pressure on the optic nerve
• IIH is not a specific indication for cesarean delivery and
patients may attempt to undergo vaginal deliveries
• Close monitoring of the patient throughout the labor
process for neurologic and ocular changes
(Anson, Vaida, Giampetro, & McQuillan, 2015; Evans & Lee, 2010; Karmaniolou et al., 2011; Kesler & Kupferminc, 2013; Leffert & Schwamm, 2013)

(Anson et al., 2015; Karmaniolou et al., 2011; Leffert & Schwamm, 2013; Month & Vaida, 2012; Moore, Meela, Keally, Crowley, McMorrow, & O’Kelly, 2014)

Idiopathic Intracranial Hypertension
Single‐shot Spinal Injection

Idiopathic Intracranial Hypertension
Indwelling Intrathecal Catheter

• Subarachnoid block (SAB) is not contraindicated in IIH as it
is with space occupying lesions
• Volume injected will translate pressure upward into the
cranium potentially increasing ICP
• Month & Vaida (2012) describe withdrawal of 5 mL of CSF
over 5 minutes prior to smallest effective volume injection
• If the patient has been managed aggressively with diuretics
or lumbar punctures, recall that reduced CSF volume will
result in greater local anesthetic spread from SAB
• For these reasons, studies suggest using the smallest
effective volume when utilizing single shot injections

• Aly & Lawther (2007) and Moore et al. (2014) both describe using
an indwelling catheter with success on laboring patients with both
vaginal and cesarean deliveries
• Benefits to indwelling intrathecal catheter:

(Anson et al., 2015; Butterworth, Mackey, & Wasnick, 2013; Karmaniolou et al., 2011, Leffert & Schwamm, 2013)

– Provide continuous labor analgesia
– Continuous monitoring of CSF pressure throughout laboring process
– Use the catheter as a drain if neurologic status declines

• Moore et al. (2014) reported ICP ranging from 25 to 27 mmHg at
rest peaking at 60 mmHg during pushing
• None of the literature suggested when to intervene or what CSF
volume to remove if intervention was needed

(Aly & Lawther, 2007; Karmaniolou et al., 2011, Moore et al., 2014)
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Idiopathic Intracranial Hypertension
Combined‐Spinal Epidural (CSE)

Idiopathic Intracranial Hypertension

• Month & Vaida (2012) described a CSE technique that
withdrew 5 mL of CSF over 5 minutes and instilled 10 mcg
fentanyl intrathecally. Patients reported improvement of
headache pain with removal of CSF
• They placed a epidural catheter with no bolus. An infusion
of 0.125% bupivacaine with fentanyl 2 mcg/mL was infused
at 6 mL/hr
• Advantage to this approach:

• Neuraxial anesthesia controversial

– Withdrawal of CSF to control symptoms
– Intrathecal fentanyl to eliminate need for bolus
– Slow epidural infusion for continued analgesia

• Disadvantage: bolus required if conversion to emergent
cesarean section
(Month & Vaida, 2012)

34

Patients with LP shunts or Optic Nerve Fenestration
– Risk of infection of the shunt
– Ineffective spinal administration – local anesthetic leaks into the
peritoneum
– Damage and malfunction of the shunt

• Kesler & Kupferminc (2013) advocate general anesthesia for
c‐section
• Karmaniolou et al. (2010) suggest performing epidurals on
an alternative interspace than the LP shunt
• Consider prophylactic anti‐biotics with neuraxial anesthesia
in the presence of a shunt
• Perform imaging prior to the removal of the catheter to
assure no shunt entanglement is present
(Anson et al., 2015; Karmaniolou et al., 2011; Kesler & Kupferminc, 2013)

Recommendations

Conclusion

• Parturients with IIH may be allowed to labor and
deliver vaginally or via cesarean section
• Epidural: Slow infusion is safe, but bolus should be
avoided making this a poor choice with possibility of
cesarean section
• Subarachnoid block may result in greater dermatomal
spread if management has depleted CSF levels. SAB is a
safe anesthetic route
• Intrathecal catheters have been used successfully to
drain CSF, monitor ICP, and provide medication delivery
• Neuraxial anesthesia requires special attention in the
presence of a lumboperitoneal shunt

• Neuraxial anesthesia continues to be the
anesthetic of choice for labor and delivery
• Idiopathic intracranial hypertension is a rare
condition with potentially serious
complications with poor anesthetic
management
• Neuraxial anesthesia can be used effectively
with certain considerations for the parturient
in the labor and delivery time period
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